128
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Intrinsic Evaluation of Antiurolithiatic Capacity of Argemone mexicana L. in Wistar Albino Rats

, , , , &
Pages 289-304 | Received 14 May 2020, Published online: 09 Mar 2021
 

ABSTRACT

The calcium oxalate reduction capacity of Argemone mexicana was demonstrated in vivo in ethylene glycol-induced urolithic rats. A. mexicana leaves extract at 400 and 750 mg kg−1 b.w. demonstrated protection of renal tubes, kidney cells and reduced the levels of serum creatinine and calcium compared to the urolithiasis induced group. Further, A. mexicana restored blood and urine markers to normal before and after treatment in urolithiasis rats and caused the breakdown of calcium oxalate crystals in the urinary tract as observed by microscopy. The A. mexicana extract protected from renal damage and repaired and increased diuresis activity thereby completely excreted calcium oxalate crystals in renal tubes. Analysis of methanolic extract of A. mexicana showed the presence of a 3,4-dihydro-3-hydroxy-7-(7-methyloctyl)naphthalen-2(1 H)-one as the bioactive compound which may be attributed to the antiurolithiatic activity.

Disclosure Statement

There is no conflict of interest by all the authors Acknowledgement.

Additional information

Funding

Department of Science and Technology-FIST, New Delhi vide File No. SR/FST/LS-1/2018/187.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.